INS and type 2 diabetes mellitus: In the streptozotocin-nicotinamide model of type 2 diabetes, the encapsulated myricitrin restored blood glucose and insulin levels and improved the total antioxidant capacity and levels of MDA, antioxidant enzymes (SOD, catalase), and apoptotic markers in the pancreas [296].